These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 27793997

  • 1. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.
    van Haren SD, Dowling DJ, Foppen W, Christensen D, Andersen P, Reed SG, Hershberg RM, Baden LR, Levy O.
    J Immunol; 2016 Dec 01; 197(11):4413-4424. PubMed ID: 27793997
    [Abstract] [Full Text] [Related]

  • 2. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.
    van Haren SD, Ganapathi L, Bergelson I, Dowling DJ, Banks M, Samuels RC, Reed SG, Marshall JD, Levy O.
    Cytokine; 2016 Jul 01; 83():99-109. PubMed ID: 27081760
    [Abstract] [Full Text] [Related]

  • 3. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.
    Lemoine S, Jaron B, Tabka S, Ettreiki C, Deriaud E, Zhivaki D, Le Ray C, Launay O, Majlessi L, Tissieres P, Leclerc C, Lo-Man R.
    J Allergy Clin Immunol; 2015 Nov 01; 136(5):1355-68.e1-15. PubMed ID: 25865351
    [Abstract] [Full Text] [Related]

  • 4. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M, Tamjidi S, Nourishirazi E, Guinet E.
    Immunol Lett; 2018 Jan 01; 193():58-66. PubMed ID: 29103998
    [Abstract] [Full Text] [Related]

  • 5. The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.
    Ganapathi L, Van Haren S, Dowling DJ, Bergelson I, Shukla NM, Malladi SS, Balakrishna R, Tanji H, Ohto U, Shimizu T, David SA, Levy O.
    PLoS One; 2015 Jan 01; 10(8):e0134640. PubMed ID: 26274907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
    Moreno Ayala MA, Gottardo MF, Gori MS, Nicola Candia AJ, Caruso C, De Laurentiis A, Imsen M, Klein S, Bal de Kier Joffé E, Salamone G, Castro MG, Seilicovich A, Candolfi M.
    J Cancer Res Clin Oncol; 2017 Sep 01; 143(9):1713-1732. PubMed ID: 28432455
    [Abstract] [Full Text] [Related]

  • 9. A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner.
    Auderset F, Belnoue E, Mastelic-Gavillet B, Lambert PH, Siegrist CA.
    Front Immunol; 2020 Sep 01; 11():580974. PubMed ID: 33262759
    [Abstract] [Full Text] [Related]

  • 10. TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.
    Cardoso EC, Pereira NZ, Mitsunari GE, Oliveira LM, Ruocco RM, Francisco RP, Zugaib M, da Silva Duarte AJ, Sato MN.
    PLoS One; 2013 Sep 01; 8(6):e67036. PubMed ID: 23826189
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.
    Philbin VJ, Dowling DJ, Gallington LC, Cortés G, Tan Z, Suter EE, Chi KW, Shuckett A, Stoler-Barak L, Tomai M, Miller RL, Mansfield K, Levy O.
    J Allergy Clin Immunol; 2012 Jul 01; 130(1):195-204.e9. PubMed ID: 22521247
    [Abstract] [Full Text] [Related]

  • 14. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR, Vasilakos JP, Deschler K, Grigsby I, Gillis P, John J, Elder MJ, Swales J, Timosenko E, Cooper Z, Dovedi SJ, Leishman AJ, Luheshi N, Elvecrog J, Tilahun A, Goodwin R, Herbst R, Tomai MA, Wilkinson RW.
    J Immunother Cancer; 2019 Sep 11; 7(1):244. PubMed ID: 31511088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 17β-Estradiol influences in vitro response of aged rat splenic conventional dendritic cells to TLR4 and TLR7/8 agonists in an agonist specific manner.
    Stojić-Vukanić Z, Nacka-Aleksić M, Bufan B, Pilipović I, Arsenović-Ranin N, Djikić J, Kosec D, Leposavić G.
    Int Immunopharmacol; 2015 Jan 11; 24(1):24-35. PubMed ID: 25479725
    [Abstract] [Full Text] [Related]

  • 17. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V, Van Overtvelt L, Horiot S, Moingeon P.
    J Immunol; 2009 Mar 15; 182(6):3372-9. PubMed ID: 19265114
    [Abstract] [Full Text] [Related]

  • 18. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH, Hayashi T, He W, Yao S, Cottam HB, Tan GS, Crain B, Krammer F, Messer K, Pu M, Carson DA, Palese P, Corr M.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.